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Changes in lung function in patients with chronic heart failure (CHF), usually reported at rest,
may be exacerbated during exercise and induce post-exercise effects. We investigated the
hypothesis that post-exercise induced changes in lung function in CHF patients are due to
the consequences of left atrial overload.
Twenty-one CHF patients and six healthy subjects (Ctrl) participated in this study. Transfer
lung capacity for carbon monoxide (TLCO) and maximal expiratory flows ð _VmaxÞ were measured
before a maximal exercise test and 1 h, 2 h and 20 h afterwards. CHF patients were divided in
two groups according to their ventilatory response to the maximal exercise test ( _VE vs. _VCO2
relationship slopes above or below 34, i.e., CHF> 34 and CHF< 34).
Compared with the Ctrl group, in CHF groups resting TLCO and _Vmax were lower. After exercise,
further changes in TLCO and _Vmax were observed in CHF> 34. TLCO per unit volume (KCO) was
increased 1 h post-exercise while maximal expiratory flow between 25 and 75% of forced vital
capacity was decreased 2 h and 20 h post-exercise. We observed a negative correlation between
the delta TLCO 1 h post-exercise from rest and the delta TLCO 2 h post-exercise from rest.
The decreases in pulmonary _Vmax we observed well after exercise following increases in KCO in
patients with high ventilatory response to exercise (CHF> 34) might indicate bronchial conges-
tion resulting from increased left atrial pressure during exercise. We propose that endurance
training should be prescribed cautiously for these patients.
ª 2008 Elsevier Ltd. All rights reserved.49 45 39 64; fax: þ33 5 49 45 33 96.
@mshs.univ-poitiers.fr (C. de Bisschop).
8 Elsevier Ltd. All rights reserved.
394 M. Roulaud et al.Introduction
Chronic heart failure (CHF) decreases the flow of oxygen and
nutrients to tissues.Apart fromthecardiovascular system,CHF
alters other functions such as respiration.1 Pulmonary impair-
ments, either obstructive or restrictive, are more severe in
patients with New York Heart Association (NYHA) high grade
heart failure.2 On one hand, congestion of bronchial vessels
caused by increased left atrial pressure has been shown to
increase airway resistance in these patients.3e5 On the other
hand, lung diffusion abnormalities develop as the disease
progresses.6,7 In the early stages of CHF, impaired diffusion
capacity is due to high capillary pressure that induces inter-
stitial oedema. Later, irreversible structural changes in the
alveolar-capillary membrane develop, decreasing resting
diffusion capacity.6,8e11 Puri et al.12 identified impaired alve-
olar-capillary membrane function as the main determinant of
resting pulmonary diffusion in NYHA class II and III patients.12
Maximal exercise capacity is generally reduced in CHF
patients, and symptoms such as dyspnea and fatigue are
exacerbated.8,9,13 Changes in resting pulmonary function
could contribute to exercise intolerance, since TLCO appears
to be a predictor of peak exercise power.7,12,14e16 In healthy
subjects, diffusion capacity increaseswith exercise intensity
up to very high levels. This adaptation of the lung to exercise
is likely to be due to increases in the gas exchange surface
that are associated with the recruitment and distension of
lung capillaries.17e19 In CHF, whether diffusion capacity
increases with exercise is controversial. Smith et al.8 and
Agostoni et al.9 have shown increases in diffusion capacity
during exercise in CHF patients, which might demonstrate
the presence of a reserve in diffusion capacity, but Messner-
Pellenc et al.16 did not observe any change in diffusion
capacity during exercise.8,9,16
Additionally, theeffects of exerciseondelayedalterations
of pulmonary function are not well understood, although it
seems important to take into account these effects when
prescribing exercise programs.20,21 Indeed, leakage of fluid
from the pulmonary vasculature into the pulmonary inter-
stitium might be induced by increases in transcapillary fluid
pressure,22 andthe repetitionof suchepisodesmightenhance
alveolar-capillary damage.10 Although changes in resting
diffusion capacity have been demonstrated in CHF, few
studies have investigated the hypothesis that exercise leads
to the development or worsening of interstitial oedema.
Similarly, an elevated pulmonary venous pressure associated
with bronchial artery exercise-induced vasodilatation might
induce micro-vascular leakage in the airway wall, causing
bronchial obstruction. The main goal of this study was to
evaluate the effect of maximal exercise test on alveolar-
capillary membrane diffusion capacity and maximal expira-
tory flows measured well after exercise in CHF patients as
compared to control subjects.
Methods
Subjects
Twenty-one patients with stable CHF (58 8 years old; 19
male, 2 female) and six healthy men (55 2 years old)
participated in this study.All CHF patients were classified in NYHA functional
classes II or III and belonged to a cohort of heart failure
patients that are monitored in the Cardiology Department
of Poitiers University Hospital. CHF patients were divided
into two groups (CHF> 34 and CHF< 34) on the basis of
their ventilatory response to a maximal exercise test
assessed by a _VE vs. _VCO2 relationship slope above or below
34 (CHF> 34 and CHF< 34 groups). _VE vs. _VCO2 slope was
calculated as the slope of the regression line relating _VE to
_VCO2 and was computed using all of the data acquired
during the maximal exercise test.
CHF patients were compared with healthy matched
controls (55 2 years) who were free of cardiopulmonary
and other diseases. For three healthy subjects in whom the
_VE vs. _VCO2 relationships during exercise were bilinear, the
initial slope was used to characterize the subjects.
CHF inclusion criteria
Patients were recruited among clinically stable CHF
patients who had been free of heart decompensation for at
least one month. All patients had an optimized stable
pharmacological treatment of heart failure, with no change
(especially in diuretic dosage) for at least two weeks.
The left ventricular ejection fraction (LVEF) obtained by
gamma-angiography was required to be less than 45%, and
chronic optimized stable pharmacological treatment of
heart failure was required to be unchanged for at least 2
weeks before testing.
CHF exclusion criteria
CHF patients with cardiac surgery, significant heart valve
disease or pacemakers were excluded. Patients were also
excluded if atrial fibrillation and significant lung disease or
other co-morbidity affecting the patient’s exercise
capacity were present. Patients with significant renal or
liver failure were also excluded.
Study design
The study required two visits to the laboratory on different
days. On the first visit, each subject completed a medical
history questionnaire, underwent a physical examination
with a 12-lead electrocardiogram (ECG) and an echocar-
diographic examination including colour B-mode Tissue
Doppler analysis (GE VingMed Vivid Five scanner equipped
with a 2.5 MHz phased array transducer, Milwaukee, Wis-
consin). During the second visit, each subject performed
a maximal exercise test. Carbon monoxide lung transfer
capacity and maximal expiratory flows were measured
before exercise, 1 and 2 h after stopping exercise and 24 h
after the first evaluations at rest. The protocol was
approved by the local Ethical Committee (CPPRB of Poitiers
University Hospital). All patients gave written informed
consent to participate in the study.
Maximal exercise test
All subjects performed a maximal exercise test on an
electrically braked stationary cycle ergometer (ERGOLINE
800S, Germany).
In CHF patients, the test began at 30 W for males and
with no load for females, and the workload was increased
by 10 W every minute. All patients were encouraged to
exercise to exhaustion, with a peak respiratory exchange
Table 1 Anthropometric data and physiological charac-
teristics of chronic heart failure (CHF) patients and healthy
subjects.
CHF patients Healthy
subjectsCHF> 34 CHF< 34
Number (male/female) 13 (11/2) 8 (8/0) 6 (6/0)
Age (years) 57 9 58 7 55 2
BMI (kg m2) 25.0 3.7 27.8 2.9 24.2 3.2
LVEF (%) 31 8* 33 7* 65 8
_VO2peak (mLmin
1 kg1) 13.2 2.5* 14.8 2.2* 29.9 5.4
Workload peak (W) 84 17* 96 15* 213 47
_VE (L min
1) 49.0 10.3* 44.9 30.4* 87.2 16.7
_VE vs. _VCO2 slope 39.8 3.3* 30.6 3.6x 30.6 3.8
Values are mean (SD); CHF> 34 and CHF< 34: CHF patients
with _VE vs. _VCO2 relationship slopes higher or lower than 34;
LVEF: left ventricular ejection fraction; BMI: body mass index;
_VO2peak : oxygen consumption at peak exercise;
_VE vs. _VCO2 slope:
slope of the regression line relating _VE to _VCO2 ; workloadpeak:
workload at _VO2peak .*p< 0.05 vs. healthy subjects; xp< 0.05 vs.
CHF> 34.
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_VO2 was
defined as the highest _VO2 recorded during the maximal
incremental exercise test. Data are expressed as raw data
and as percentages of predicted (% pred) _VO2 .
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In healthy subjects, after a 5-min warm-up at 90 W, the
test began at 100 W, and the workload was increased by
25 W every minute. The test ended when the subject was
no longer able to cycle, despite maximal voluntary effort
and encouragement. Criteria for maximal oxygen
consumption ð _VO2maxÞ determination were i) stabilization of
_VO2 despite a further increase in workload, ii) attainment of
the age-predicted maximal heart rate (220-age), and iii)
a respiratory exchange ratio >1.1.
Subjects breathed through a facemask (Hans Rudolph,
Kansas City, Mo, USA). Expired gas flow was measured using
a pneumotachograph (Type 3, Hans Rudolph, Kansas City,
MO,USA) and analyzed breath-by-breath using an automated
system (Me´disoft, Exp’air 1.26, Belgium, 1999). Before each
test, the pneumotachograph was manually calibrated with
a 3 L syringe and gas analyzers with a gas mixture of known
composition vs. room air composition. _VO2,
_VCO2,
_VE,
breathing frequency, respiratory exchange ratio and other
common respiratory parameters were monitored continu-
ously breath-by-breath and averaged every 15 s. Heart rate
was continuously recorded using a 12-lead ECG.
Pulmonary flows and volumes
Spirometry was performed with a Sensor Medics Vmax
Spectra instrument (Anaheim, California, USA). Forced
expiratory volume in 1 s (FEV1), mean expiratory flow
between 25 and 75% (MEF25e75), and forced vital capacity
(FVC) were measured during a forced vital capacity
maneuver. Results were expressed as raw data and as %
pred values.24
Carbon monoxide lung transfer capacity
Transfer lung capacity for carbon monoxide (TLCO) was
measured using a single breath method in the sitting posi-
tion as previously described25 (Sensor Medics Vmax Spectra,
Anaheim, California, USA). The concentrations of inspira-
tory gas were 3000 ppm CO, 3000 ppm acetylene, 3000 ppm
methane, and 21% oxygen, and the remainder was nitrogen.
The breathing maneuver involved expiration to residual
volume, a vital capacity inspiration of the gas mixture fol-
lowed by a 10 s breath hold, and expiration to residual
volume. Alveolar gas was sampled for analysis in a balloon
after discarding the first 0.6 L of expired gas to purge
experimental and anatomic dead space. Alveolar volume
(VA) and TLCO were expressed as raw data and as % pred
values. Data were corrected for hemoglobin concentrations
(g dL1). Transfer factor per unit volume, i.e., TLCO/VA
(KCO) was calculated. To ensure that all measurements
were made under the same conditions, heart rate was
checked before each TLCO measurement.
Statistical analysis
Data are expressed as mean values SD. Statistical anal-
yses were performed using the Statistica 5.1 package
(Statsoft, Inc., Tulsa, OK, USA). Analysis of variance
(ANOVA) tests were used to assess comparisons between
the groups and to evaluate differences between baseline
and post-exercise measurements. NewmaneKeuls testswere used for post hoc tests. Paired t-tests were applied
whenever appropriate. Correlations were assessed by
univariate linear regression analysis. p values less than 0.05
were considered significant.
Results
Subject characteristics and the results of the incremental
maximal exercise test are reported in Table 1. Nine CHF
patients were classified as being in NYHA functional class II
and twelve were in functional class III. Thirteen CHF patients
with _VE vs. _VCO2 relationship slopes ranging from 35 to 44
during the maximal exercise test were placed in a CHF> 34
group. The eight remaining CHF patients had _VE vs. _VCO2
relationship slopes between 24 and 33. The two CHF groups
displayed lower _VO2peak and workloadpeak values than the
healthy group. When expressed as % pred, _VO2peak values were
43 8% in CHF> 34, 50 5% in CHF< 34 and 87 22% in the
healthy group. _VO2peak and workload did not differ between
the CHF> 34 and CHF< 34 groups. As expected LVEF (%) was
significantly decreased in CHF patients, but did not differ
between the two subgroups (CHF> 34 and CHF< 34). None
of them had an estimated mean pulmonary arterial pressure
above 40 mmHg, or an estimated pulmonary capillary pres-
sure above 20 mmHg, at rest.
Respiratory variables
Respiratory variables before and after exercise for the
three groups are presented in Tables 2 and 3.
Baseline values
At rest before exercise, the two CHF groups had lower VA,
TLCO, FEV1 and FVC as expressed in % pred than the healthy
group, whereas FEV1/FVC ratios were normal (Fig. 1). There
were no differences between the two CHF groups. The
same differences between CHF and healthy groups were
observed for raw data except for VA. KCO was also
Table 2 Respiratory variables at baseline.
VA
(L)
TLCO
(ml min1
mmHg1)
KCO FVC
(L)
FEV1
(L)
MEF25e75
(L s1)
FEV1/FVC
CHF> 34 5.53 1.02 19.9 5.1* 3.64 0.7* 3.58 1.02* 2.57 0.7* 1.85 0.65 72 6
CHF< 34 5.52 0.58 21.8 4.1* 3.93 0.5* 3.77 0.22* 2.54 0.6* 1.75 0.87 67 13
Healthy 6.34 0.53 29.2 2.9 4.61 0.1 4.93 0.48 3.53 0.35 2.74 0.71 72 6
Values are mean SD. CHF> 34 and CHF< 34: CHF patients with _VE vs. _VCO2 relationship slopes higher or lower than 34; TLCO: transfer
lung capacity for carbon monoxide; KCO: transfer factor per unit volume; FVC: forced vital capacity; FEV1: forced expiratory volume in
1 s; MEF25e75: maximal expiratory flow between 25 and 75 % FVC; *p< 0.05 vs. healthy subjects.
396 M. Roulaud et al.significantly lower in the two CHF groups than in the
healthy group.
Post-exercise values
After exercise, TLCO did not change in any group, whereas
KCO increased significantly 1 h after stopping exercise in the
CHF> 34 group (p< 0.05; Fig. 2) as compared to resting
values. KCO returned to its baseline value 2 h after stopping
exercise. In the CHF> 34 group TLCO was slightly increased
1 h after exercise, whereas VA did not vary at any time
(Fig. 3). A negative correlation was observed in CHF> 34
group between the delta TLCO 1 h (TLCO 1 h post-
exercise TLCO rest) and the delta TLCO 2 h (TLCO 2 h post-
exercise TLCO rest) (rZ0.58; p< 0.05).
Neither FEV1 nor FVC changed after exercise in any
group. MEF25e75 (% pred) was significantly lower 2 h and
20 h after stopping exercise in the CHF> 34 group
(p< 0.05) (Fig. 4). FEV1/FVC was also lower 2 h after
stopping exercise in this group.
Discussion
The main finding of this study was that diffusion capacity
and maximal expiratory flows worsen after exercise in CHF
patients whose _VE vs. _VCO2 relationship slopes are above 34.Table 3 Respiratory variables before and after maximal exerci
Baseline
VA (% pred) CHF> 34 85 11
CHF< 34 86 6
Healthy 98 8
TLCO (% pred) CHF> 34 73 16*
CHF< 34 82 14*
Healthy 106 10
FEV1 (% pred) CHF> 34 80 15*
CHF< 34 82 18*
Healthy 109 11
FVC (% pred) CHF> 34 89 17*
CHF< 34 97 6*
Healthy 122 9
MEF25e75 (% pred) CHF> 34 53 15
CHF< 34 50 23
Healthy 70 20
Values are expressed in percentage predicted (% pred) and are mea
relationship slopes higher or lower than 34; 1 h PE: 1 h post-exercise;
volume; TLCO: transfer lung capacity for carbon monoxide; FVC: force
maximal expiratory flow between 25 and 75% FVC; xp< 0.05 vs. baseliPatient characteristics and classification
In healthy subjects, during incremental exercise, the rela-
tionship between _VE and _VCO2 is linear below the ventilatory
compensation point. The ventilatory response can be
characterized by the slope of the relationship between the
two variables. In CHF patients, the slope of this relation is
increased such that for a given level of CO2 production,
ventilation is higher than normal.26e31 This increase in _VE
has been attributed to an increase in VD/VT due to venti-
lation/perfusion mismatching, to increased _VCO2 relative to
_VO2 resulting from HCO3
 buffering of lactic acid, to
decreased PaO2 and to the tight regulation of arterial pH.
32
This excessive ventilatory response is considered to be
a common characteristic of patients with CHF, and
impaired exercise tolerance is predictive of mortality in
patients with advanced CHF.31 Because Guazzi et al.11 have
reported that membrane conductance (Dm) impairment is
correlated with exercise ventilation efficiency, we chose to
analyse data in CHF patients using _VE vs. _VCO2 relationship
slopes. The CHF patients enrolled in this study were grou-
ped according to a cut-off slope of 34, which is considered
to be the upper normal limit for this value.26
Peak oxygen uptake is also considered by some
researchers to be a powerful predictor of outcomes.33 Usingse test.
1 h PE 2 h PE 20 h PE
83 12 82 11 83 11
84 6 86 4 89 7
96 8 95 10 95 15
76 20* 70 13* 71 14*
79 14* 80 13* 82 13*
101 8 101 14 100 17
79 14* 79 14* 78 14*
83 19* 80 18* 81 21*
110 13 108 14 106 15
90 16* 90 13* 89 14*
98 6* 96 8* 99 10*
123 12 122 12 118 15
48 20 46 19x 45 18x
51 27 49 25 47 22
72 27 66 25 72 28
ns SD. CHF> 34 and CHF< 34: CHF patients with _VE vs. _VCO2
2 h PE: 2 h post-exercise; 20 h PE: 20 h post-exercise; VA: alveolar
d vital capacity; FEV1: forced expiratory volume in 1 s; MEF25e75:
ne; p< 0.05 vs. 1 h PE and 2 h PE; *p< 0.05 vs. healthy subjects.
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Figure 1 Baseline values of respiratory variables in the two
CHF groups and in the healthy group. VA: alveolar volume;
TLCO: transfer lung capacity for carbon monoxide; FEV1: forced
expiratory volume in 1 s; MEF25e75: maximal expiratory volume
between 25 and 75% of forced vital capacity; FVC: forced vital
capacity; % pred: data expressed as percentages of predicted
values; CHF> 34: chronic heart failure subjects with _VE vs.
_VCO2 relationship slopes >34; CHF< 34: chronic heart failure
subjects with _VE vs. _VCO2 relationship slopes <34; ) signifi-
cantly different from healthy group (p< 0.05).
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Figure 3 Transfer lung capacity for carbon monoxide (TLCO)
and alveolar volume (VA) in chronic heart failure subjects with
_VE vs. _VCO2 relationship slopes >34 at baseline and 1, 2 and
20 h after the maximal exercise test.
Exercise and lung function in chronic heart failure 397a 14 mlmin1 kg1 cut-off value as determined by Mancini
et al.34 to identify patients who could benefit from trans-
plants, we did not observed any difference in respiratory
response (expiratory flows and diffusion variables) after
exercise between the groups. Using our classification
scheme, similar percentages of subjects had
a _VO2peak < 14 ml min
1 kg1 in the two CHF groups (46% in
the CHF> 34 group and 50% in the CHF< 34 group).
Resting pulmonary function in CHF patients
Our study confirms that diffusion capacity is impaired in
CHF patients since TLCO was significantly lower than that of
healthy subjects. Diffusion of gases through the alveolar
space and the blood is often described using Roughton and
Forster’s model.35 In this model, the transfer of CO is2.5
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K
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Figure 2 Transfer factor per unit volume in the two chronic
heart failure groups and in the healthy group at baseline and
after the maximal exercise test. KCO: transfer factor per unit
volume; CHF> 34: chronic heart failure subjects with _VE vs.
_VCO2 relationship slopes >34; CHF< 34: chronic heart failure
subjects with _VE vs. _VCO2 relationship slopes <34; ): chronic
heart failure groups significantly different from the healthy
group (p< 0.05); x: different from baseline and other post-
exercise values.a function of two components: the alveolo-capillary
membrane characterized by the conductance of CO ðDmCOÞ
and the product of red blood cell conductance for CO (qCO)
and pulmonary capillary volume (Vc). Impairments in TLCO
observed in CHF patients are likely due to changes in DmCO,
since the increases in pulmonary capillary pressure
commonly observed in these patients have been shown to
induce alveolar epithelial and pulmonary endothelial
damage in experimental models.36 Puri et al.12,15 have
identified changes in DmCO as the major determinant of
impaired pulmonary gas transfer, showing that alveolo-
capillary membrane resistance accounts for 63 and 86% of
total pulmonary diffusive resistance in NYHA II and NYHA III
patients, respectively, as compared with 53% in control
subjects. Moreover, Guazzi et al.11 demonstrated that Dm
was the only variable that correlates with _VE vs. _VCO2
relationship slopes (rZ0.35, p< 0.005). Therefore, the
decreases in TLCO we observed in CHF< 34 which were
accentuated in CHF> 34 are consistent with changes in Dm.
However, decreases in Dm are not fully reflected by
decreases in TLCO, since increased Vc due to increased lung25
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Figure 4 Maximal expiratory flow between 25 and 75% of
forced vital capacity (MEF25e75) and transfer factor per unit
volume (KCO) in chronic heart failure subjects with _VE vs. _VCO2
relationship slopes >34 at baseline and 1, 2 and 20 h after the
maximal exercise test. x: significantly different from baseline
(p< 0.05).
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phenomenon.
FEV1 and FVC were also lower at rest in CHF patients,
especially in the CHF> 34 group, while FEV1/FVC was not
altered. These results are in agreement with those of
previous studies.2,7,32,37
Pulmonary function well after exercise
A significant increase in KCO was observed 1 h after exercise
in the CHF> 34 group, whereas VA was unchanged. Because
an increase in DmCO is unlikely in these patients, the
increase in KCO likely resulted from an increase in Vc
induced by increased pulmonary capillary pressure. The
negative correlation observed between delta TLCO 1 h (1 h
post-exercise baseline values) and delta TLCO 2 h (2 h
post-exercise baseline values) in the CHF> 34 group
might be due to increased pulmonary capillary pressure
during exercise and for the first hour of recovery, followed
by leakage of fluid from the pulmonary vasculature into the
pulmonary interstitium.38 Increases in pulmonary capillary
pressure concomitant with exercise intensity have been
attributed to haemodynamic backward effects caused by
elevated left ventricular end-diastolic pressure.39,40 The
associated decrease in MEF25e75 in this same group of
patients 2 h and 20 h after stopping exercise might result
from bronchial congestion. Increased left atrial pressure
can also induce congestion of the bronchi, reducing internal
airway diameter.3 Since in our patients estimated mean
pulmonary arterial pressure was <40 mmHg, and mean
pulmonary capillary pressure was <20 mmHg at rest, it is
likely, even if it is not measured, that the increase in
capillary pressure at exercise was not enough important to
induce a large fluid leak in the walls of the airways.
In this study, pulmonary changes after exercise were
only observed in the CHF group with _VE vs. _VCO2 relationship
slopes above the upper normal limit.26 This result suggests
that maximal exercise could have deleterious effects on
alveolar-capillary membranes in severe CHF patients that
could worsen damage to the alveolar-capillary membrane.
Simultaneous measurements of Vc and DmCO would be
required to precisely assess the consequences of exercise
on the different components involved in alveolar-capillary
transfer. Investigating the pulmonary response to sub-
maximal exercise in CHF subjects with _VE vs. _VCO2 rela-
tionship slopes >34 would be also relevant to assess the
safety of less intense exercise.
Exercise in chronic heart failure
Because we have shown that intense exercise can induce
changes in pulmonary function in severe CHF patients, the
beneficial effects of exercise programs for these patients
must be questioned. Indeed, it is well known that when the
alveolar-capillary membrane is chronically challenged,
remodelling takes place via ultrastructural changes.10,39,41
Under these conditions, it seems wise to assume that
impaired gas diffusion,which is alreadypresent at rest in CHF
patients, might be worsened by repeated exercise sessions.
Whereas 15 years ago exercise was contra-indicated for
patients with CHF, treatments have changed dramaticallyduring the last few years, and several studies have shown
that training programs are highly efficient in improving
exercise capacity and symptoms.20,42,43 These numerous
benefits have been largely attributed to skeletal muscle
effects, but improvement in lung diffusion capacity after 8
weeks of endurance training has also been reported by
Guazzi et al.21 in CHF patients. The latter study stated that
repeated episodes of exercise might act as chronic stimuli,
inducing the release of endothelial paracrine signals that
help control vascular tone and permeability. These effects
could affect not only systemic endothelial function (or in
a more restrictive manner, exercising limbs) but also the
entire vasculature including the lung, explaining improve-
ments in pulmonary gas transfer.
Because muscle atrophy is a hallmark of CHF,44 recent
studies have proposed other exercise programmes based on
peripheral muscle training, including resistance exercise or
strength exercise, which do not produce great cardiovas-
cular stress.43,45 In most studies, strength training has
proven to be as efficient as endurance training or combined
endurance-strength training focusing on peak _VO2 that
integrates central and peripheral components.46,47
Therefore, incorporating the results of our study, we
suggest that exercise training be prescribed with caution
for CHF patients with high ventilatory responses to exercise
( _VE vs. _VCO2 relationship slopes >34). In these patients, it
seems important to avoid large cardiovascular stresses that
could induce alveolar-capillary and bronchial damage. Sub-
maximal continuous exercise or other modalities of training
based on strength exercises or interval exercises, which act
as intense stimuli for peripheral muscles, could be more
appropriate for subjects with poor ventilatory efficiency
during exercise.
In summary, this study has shown that in CHF patients
displaying high ventilatory responses to exercise, maximal
exercise might accentuate changes in pulmonary diffusion
and in maximal expiratory flows that are already present at
rest. The decreases in pulmonary variables observed well
after exercise provide evidence for the development of
oedema of airway walls. These findings should been taken
into account before prescribing exercise.
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